228 related articles for article (PubMed ID: 20971737)
1. Matriptase is involved in ErbB-2-induced prostate cancer cell invasion.
Wu SR; Cheng TS; Chen WC; Shyu HY; Ko CJ; Huang HP; Teng CH; Lin CH; Johnson MD; Lin CY; Lee MS
Am J Pathol; 2010 Dec; 177(6):3145-58. PubMed ID: 20971737
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-targeting pericellular serine protease matriptase role in suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Cheng TS; Chen WC; Lin YY; Tsai CH; Liao CI; Shyu HY; Ko CJ; Tzeng SF; Huang CY; Yang PC; Hsiao PW; Lee MS
Cancer Prev Res (Phila); 2013 May; 6(5):495-505. PubMed ID: 23466486
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis.
Ko CJ; Lan SW; Lu YC; Cheng TS; Lai PF; Tsai CH; Hsu TW; Lin HY; Shyu HY; Wu SR; Lin HH; Hsiao PW; Chen CH; Huang HP; Lee MS
Oncogene; 2017 Aug; 36(32):4597-4609. PubMed ID: 28368394
[TBL] [Abstract][Full Text] [Related]
4. Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.
Ko CJ; Huang CC; Lin HY; Juan CP; Lan SW; Shyu HY; Wu SR; Hsiao PW; Huang HP; Shun CT; Lee MS
Cancer Res; 2015 Jul; 75(14):2949-60. PubMed ID: 26018085
[TBL] [Abstract][Full Text] [Related]
5. HAI-2 suppresses the invasive growth and metastasis of prostate cancer through regulation of matriptase.
Tsai CH; Teng CH; Tu YT; Cheng TS; Wu SR; Ko CJ; Shyu HY; Lan SW; Huang HP; Tzeng SF; Johnson MD; Lin CY; Hsiao PW; Lee MS
Oncogene; 2014 Sep; 33(38):4643-52. PubMed ID: 24121274
[TBL] [Abstract][Full Text] [Related]
6. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin.
Webb SL; Sanders AJ; Mason MD; Jiang WG
Oncol Rep; 2012 Oct; 28(4):1491-7. PubMed ID: 22858929
[TBL] [Abstract][Full Text] [Related]
7. Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis.
Najy AJ; Dyson G; Jena BP; Lin CY; Kim HR
Am J Physiol Cell Physiol; 2016 Feb; 310(4):C293-304. PubMed ID: 26157007
[TBL] [Abstract][Full Text] [Related]
8. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
Lee MS; Igawa T; Yuan TC; Zhang XQ; Lin FF; Lin MF
Oncogene; 2003 Feb; 22(5):781-96. PubMed ID: 12569372
[TBL] [Abstract][Full Text] [Related]
9. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
10. Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.
Lee CF; Dang A; Hernandez E; Pong RC; Chen B; Sonavane R; Raj G; Kapur P; Lin HY; Wu SR; Ko CJ; Lo UG; Lee HY; Hsieh JT; Lee MS
Oncogene; 2019 Jul; 38(28):5580-5598. PubMed ID: 31152147
[TBL] [Abstract][Full Text] [Related]
11. Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
Tripathi M; Potdar AA; Yamashita H; Weidow B; Cummings PT; Kirchhofer D; Quaranta V
Prostate; 2011 Feb; 71(2):184-96. PubMed ID: 20672321
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
[TBL] [Abstract][Full Text] [Related]
14. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.
Tsui KH; Chang PL; Feng TH; Chung LC; Sung HC; Juang HH
Anticancer Res; 2008; 28(4A):1993-9. PubMed ID: 18649738
[TBL] [Abstract][Full Text] [Related]
17. A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer.
Ustach CV; Huang W; Conley-LaComb MK; Lin CY; Che M; Abrams J; Kim HR
Cancer Res; 2010 Dec; 70(23):9631-40. PubMed ID: 21098708
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
Förbs D; Thiel S; Stella MC; Stürzebecher A; Schweinitz A; Steinmetzer T; Stürzebecher J; Uhland K
Int J Oncol; 2005 Oct; 27(4):1061-70. PubMed ID: 16142324
[TBL] [Abstract][Full Text] [Related]
19. EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.
Cortés MA; Cariaga-Martinez AE; Lobo MV; Martín Orozco RM; Motiño O; Rodríguez-Ubreva FJ; Angulo J; López-Ruiz P; Colás B
Carcinogenesis; 2012 Jun; 33(6):1169-77. PubMed ID: 22461520
[TBL] [Abstract][Full Text] [Related]
20. Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.
Caggia S; Chunduri H; Millena AC; Perkins JN; Venugopal SV; Vo BT; Li C; Tu Y; Khan SA
J Cell Physiol; 2018 Jan; 234(1):802-815. PubMed ID: 30078221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]